These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23716903)

  • 1. Clofazimine-induced enteropathy in a patient of leprosy.
    Singh H; Azad K; Kaur K
    Indian J Pharmacol; 2013; 45(2):197-8. PubMed ID: 23716903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient.
    Sukpanichnant S; Hargrove NS; Kachintorn U; Manatsathit S; Chanchairujira T; Siritanaratkul N; Akaraviputh T; Thakerngpol K
    Am J Surg Pathol; 2000 Jan; 24(1):129-35. PubMed ID: 10632497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
    Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
    Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Small intestine transit anomalies in a patient with chronic abdominal pain and treated for Hansen's disease].
    Davy C; Riveau E; Bousquet JC; Curet P; Vayre P; Cortez A; Grellet J
    J Radiol; 1986 Mar; 67(3):213-8. PubMed ID: 3528476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.
    Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ
    Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe abdominal pain in low dosage clofazimine.
    Chong PY; Ti TK
    Pathology; 1993 Jan; 25(1):24-6. PubMed ID: 8316494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Unusual Ileal Discoloration.
    Dhillon AS; Johnston EL; Sanderson JD
    Gastroenterology; 2018 Jul; 155(1):e1-e2. PubMed ID: 28989061
    [No Abstract]   [Full Text] [Related]  

  • 9. Photosensitisation induced by clofazimine in a cat.
    Bennett Sl
    Aust Vet J; 2007 Sep; 85(9):375-80. PubMed ID: 17760943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and hematological side effects of clofazimine in leprosy patients.
    Costa Queiroz RH; de Souza AM; Sampaio SV; Melchior E
    Pharmacol Res; 2002 Aug; 46(2):191-4. PubMed ID: 12220960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clofazimine: detailed studies of small intestine functions.
    Bhasin DK; Kumar B; Broor SL; Kaur S; Malik AM; Mehra SK
    Indian J Lepr; 1985; 57(2):364-72. PubMed ID: 4078364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR; Spencer TI; Ladizinski B
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract]   [Full Text] [Related]  

  • 13. Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient.
    Barot RK; Viswanath V; Pattiwar MS; Torsekar RG
    Indian J Ophthalmol; 2011; 59(4):328-9. PubMed ID: 21666328
    [No Abstract]   [Full Text] [Related]  

  • 14. Complications of treatment with clofazimine (Lamprene: B663).
    Jopling WH
    Lepr Rev; 1976 Mar; 47(1):1-3. PubMed ID: 1263731
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection.
    Garrelts JC
    DICP; 1991 May; 25(5):525-31. PubMed ID: 2068838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
    Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
    Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-intestinal side effects of clofazimine.
    Lal S; Garg BR; Hameedulla A
    Lepr India; 1981 Apr; 53(2):285-8. PubMed ID: 7253579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofazimine: new products. Major antileprous drug.
    Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross-sectional study.
    Nogueira AS; Garcia MAC; Silva MBD; Costa PFD; Frade MAC; Salgado CG; Barreto JG
    Trop Med Int Health; 2024 Apr; 29(4):327-333. PubMed ID: 38348585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
    Singh H; Nel B; Dey V; Tiwari P; Dulhani N
    Lepr Rev; 2011 Mar; 82(1):17-24. PubMed ID: 21644468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.